Category Gastroenterology/Intestinal Diseases
Press Release
Research Shows Cooking Classes Have Positive Impact on Participants’ Microbiome
A University of Chicago team is exploring how a series of cooking classes, focused on nutrition and making better food choices, impact participants’ gastrointestinal microbiomes and overall health. Supported in part by the GI Research Foundation, they are seeing quick improvements to participants’ gut health that may motivate people to keep eating better. Read More
Press Release
Healing the Wounds of Inflammatory Bowel Disease
A University of Chicago team identified a special type of stem cell that heals damaged bowel tissue in mice, a discovery that may have direct application to humans with inflammatory bowel disease. These early findings, made possible with seed funding from the GI Research Foundation, resulted in a recent five-year, $2.5 million grant from the National Institutes of Health to study those cells in humans. Read More
Press Release
EndoFresh Obtains FDA 510(k) Clearance for Its Groundbreaking Disposable Digestive Endoscopy System
EndoFresh reveals its novel Disposable Digestive Endoscopy System with full advantages of potential clinical application, patient safety and financial implication, which is approved by the FDA and CE. It is perfect for gastrointestinal endoscopy, effectively helping physicians in ICU, ER, outpatient clinic, GI suite and bed-side treatment, especially during post-pandemic era. Read More
Press Release
Cernostics Announces Blinded, Independent Validation of TissueCypher(R) Performance for Predicting Risk of Progression to Esophageal Cancer in Patients With Non-Dysplastic BE
Study further validates TissueCypher(R) as the first and only precision medicine test proven to provide actionable data for predicting patient progression to high-grade dysplasia and esophageal adenocarcinoma Read More
Press Release
Gencia, LLC Will Present Preclinical Results in the DIAMOND Mice Supporting the Therapeutic Potential of Its Lead Mitochondrial Therapeutic, GEN-3026, to Treat NASH at the International Liver CongressTM, Paris, France, April 11-15 2018
Results Demonstrate that GEN-3026 Successfully Met the Primary Study Endpoint of Treating and Preventing Progression of NASH Read More
Press Release